Appelhans Dannielle bought HALO
September 1, 2026 · Form 4 insider transaction
Appelhans Dannielle bought 1,161 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,161
Price
$0.00
Total value
N/A
InsiderAppelhans Dannielle
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateSeptember 1, 2026
Filing dateSeptember 2, 2026
Shares owned after1,161
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the date of the Issuer's 2027 annual meeting of stockholders.